EFFECTS OF NS-398, A SPECIFIC INHIBITOR FOR CYCLOOXYGENASE-2, ON GASTRIC CELL-PROLIFERATION

被引：0
|
作者：
TSUJII, S [1 ]
SAWAOKA, H [1 ]
KAWANO, S [1 ]
TAKEI, Y [1 ]
NAGANO, K [1 ]
FUSAMOTO, H [1 ]
KAMADA, T [1 ]
机构：
[1] OSAKA UNIV,SCH MED,DEPT MED,SUITA,OSAKA 565,JAPAN
来源：
GASTROENTEROLOGY | 1995年 / 108卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A245 / A245
页数：1
相关论文
共 50 条
  • [41] Novel effects of the cyclooxygenase-2-selective inhibitor NS-398 on IL-1-induced cyclooxygenase-2 and IL-8 expression in human ovarian granulosa cells
    Ou, Hui-Ling
    Sun, David
    Peng, Yen-Chun
    Wu, Yuh-Lin
    INNATE IMMUNITY, 2016, 22 (06) : 452 - 465
  • [42] Expression of cyclooxygenase 2 (COX-2) in human glioma and in Vitro inhibition by a specific COX-2 inhibitor, NS-398
    Joki, T
    Heese, O
    Nikas, DC
    Bello, L
    Zhang, JP
    Kraeft, SK
    Seyfried, NT
    Abe, T
    Chen, LB
    Carroll, RS
    Black, PM
    CANCER RESEARCH, 2000, 60 (17) : 4926 - 4931
  • [43] NS-398 (a Selective Cyclooxygenase-2 Inhibitor) Decreases Agonist-Induced Contraction of the Human Ureter via Calcium Channel Inhibition
    Lee, Shin Young
    Lee, Moo Yeol
    Park, Soo Hyun
    Kim, Tae Hyoung
    Moon, Young Tae
    Han, June Hyun
    Myung, Soon Chul
    JOURNAL OF ENDOUROLOGY, 2010, 24 (11) : 1863 - 1868
  • [44] Selective cyclooxygenase-2 inhibitor NS-398 attenuates myocardial fibrosis in mice after myocardial infarction via Snail signaling pathway
    Chi, Y. -C.
    Shi, C. -L.
    Zhou, M.
    Liu, Y.
    Zhang, G.
    Hou, S. -A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (24) : 5805 - 5812
  • [45] Cyclooxygenase-2 inhibition with NS-398 decreases the number of cells in S-phase in transitional cell carcinoma of the bladder.
    Gee, JR
    Lee, I
    Fischer, SM
    Sabichi, AL
    Grossman, H
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3813S - 3813S
  • [46] Characterization of inhibited growth of cyclooxygenase-2 (COX-2) expressing human hepatoma cells by a selective COX-2 inhibitor (NS-398).
    Hu, KQ
    McCracken, J
    Mineyama, Y
    Yu, CH
    Hillebrand, D
    HEPATOLOGY, 2001, 34 (04) : 388A - 388A
  • [47] NS-398: Cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation
    Bozza, PT
    Pacheco, P
    Yu, W
    Weller, PF
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 67 (04): : 237 - 244
  • [48] Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats
    Tunctan, Bahar
    Korkmaz, Belma
    Cuez, Tuba
    Buharalioglu, C. Kemal
    Sahan-Firat, Seyhan
    Falck, John
    Malik, Kafait U.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107 (05) : 877 - 882
  • [49] NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines
    Cheng, JD
    Imanishi, H
    Amuro, Y
    Hada, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (05) : 755 - 761
  • [50] Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells
    Cheng, ASL
    Chan, HLY
    Leung, WK
    Wong, N
    Johnson, PJ
    Sung, JJY
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (01) : 113 - 119
12345